Follow Us TR

News Details

Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™

About Immunomedics, Inc.
  • NASDAQ: $IMMU
  • Notified: $40.64
  • 08:01 EDT

Price Chart